기업공개 보도자료
-
- 바이오사이토젠, 커촹반 상장 완료… 최초의 ‘H+A’ 글로벌 신약 혁신 기업으로 도약
- 혁신 신약 개발을 선도하는 글로벌 바이오테크 기업 바이오사이토젠 파마슈티컬스(베이징)(Biocytogen Pharmaceuticals (Beijing) Co., Ltd.), 이하 바이오사이토젠, 상하이증권거래소 688796, 홍콩증권거래소 02315)이 상하이증권거래소 커촹반(STAR Market) 상장에...
- 10:00
-
- Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), a global biotechnology company advancing innovative drug discovery, today announced its successful listing on the Shanghai Stock Exchange STAR Market. This fo...
- 10:00
-
- K2 MEDITECH Sets a New Benchmark in the Global Skin Booster Market
- Built on innovative skin-regeneration technology, K2 MEDITECH is rapidly gaining attention in the global beauty and medical aesthetics industries. As a specialized manufacturer of skin boosters, the company is recognized not merely as a product su...
- 11월 21일 14:07
